Education and Early Career

 

Dr. Kye began his medical journey at Northwestern University, where he was part of the Honors Program in Medical Education, a prestigious accelerated six-year program combining undergraduate and medical studies. He earned his B.A. in Medicine in 1987 and completed his M.D. in 1990. During his time at Northwestern, Dr. Kye was awarded a fellowship at the NIH Basic Neuroscience Research Fellowship, where he studied under Toshio Narahashi, a renowned neuropharmacologist. This experience fostered a deep understanding of neurophysiology, evidenced by his publication on the effects of ethanol on voltage-activated calcium channels.

 

Following medical school, Dr. Kye pursued a combined general psychiatry residency and a child psychiatry fellowship at the University of Pittsburgh Medical Center (UPMC). Here, he engaged in significant clinical research in mood disorders, working under experts like Dr. Neal Ryan and Dr. Ronald Dahl. His work contributed to important publications and earned him the Peter Henderson Award for outstanding research in child and adolescent psychiatry.

 

 

NIH Fellowship and Focus on Neuroscience

 

Dr. Kye's profound interest in the developmental aspects of neural circuitry was further shaped during a three-year NIH clinical psychiatry fellowship at UPMC under the guidance of Dr. David A. Lewis, Chairman of the Department of Psychiatry and head of the NIMH Conte Center for Translational Mental Health Research. This fellowship allowed him to explore the developmental microcircuitry of the non-human primate prefrontal cortex, igniting a lifelong passion for understanding developmental neuroscience that has greatly influenced his clinical approach.

 

 

Clinical Practice and Specialization

 

Dr. Kye's clinical practice focuses on the needs of children with autism and individuals with mood disorders who have proven resistant to standard treatments. His approach is rooted in a deep understanding of neuroscience, leveraging his research background to enhance patient care. Dr. Kye explains, "Understanding the brain's functioning at a molecular and circuitry level allows me to tailor treatments that are truly effective, particularly in complex cases where conventional methods fall short.”

 

 

Contributions to Psychiatry and Community Involvement

 

A committed educator and speaker, Dr. Kye regularly shares his knowledge on neuropsychiatric topics at various institutions and conferences, including the Center for Autism and Related Disorders at Florida Atlantic University and the National Alliance on Mental Illness. His presentations often focus on the practical application of neuroscience in clinical settings, aiming to improve patient outcomes by better understanding brain-behavior relationships.

 

Dr. Kye is an active member of several professional organizations, including the Society of Biological Psychiatry and the American Academy of Child and Adolescent Psychiatry. His commitment to advancing the field is also evident in his role on the Associate Board of Directors for the National Alliance on Mental Illness in Palm Beach County, where he was honored with the 2015 Exemplary Psychiatrist Award.

 

​

Philosophy and Patient Care

 

Dr. Kye is deeply committed to his patients, stating, "My goal is not just to treat symptoms but to enhance each patient's overall well-being. Neuroscience isn't just academic for me—it's a crucial foundation that enhances my ability to care for my patients effectively.”

 

 

Research Publications

 

Twombly DA, Herman MD, Kye CH, Narahashi T. (1990). "Ethanol effects on two types of voltage-activated calcium channels." Journal of Pharmacological Experimental Therapeutics, 254(3):1029-37.

A study on how ethanol impacts calcium channels, highlighting implications for neuropharmacology.

 

Kye CH, Ryan ND. (1995). "Pharmacologic Treatment and Adolescent Depression." Child and Adolescent Psychiatric Clinics of North America, 4(2):261-281.

This paper discusses the options and considerations in the pharmacological treatment of depression in adolescents.

​

Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyengar S, Dachille S. (1996). "A randomized, controlled trial of amitriptyline in the acute treatment of adolescent depression." Journal of the American Academy of Child and Adolescent Psychiatry, 35(9):1139-44.

Results from a clinical trial examining the efficacy of amitriptyline in treating adolescent depression.

 

Kaye WH, Gendall K, Kye C. (1998). "The role of the central nervous system in the psychoneuroendocrine disturbances in anorexia and bulimia nervosa." Psychiatric Clinics of North America, 21(2):381-96.

This publication explores the neurological and endocrine disturbances associated with eating disorders, providing insights into potential treatment paths.

​

Woo TU, Pucak ML, Kye CH, Matus CV, Lewis DA. (1997). "Peripubertal refinement of the intrinsic and associational circuitry in monkey cortex." Neuroscience, 23(10):880-3.

A study on the changes in neural circuitry during the peripubertal period in non-human primates, contributing to understanding of developmental neuroscience.

​

​

​

Recent Lectures

​

Event: FAU CARD Conference, Orlando, FL

Date: January 13, 2024

Presenters: Dr. Christopher Kye, MD, PA and Cheryl Checkers, M.S., LMHC, NCC

Title: Understanding and Supporting the Mental Health of Individuals with Autism: Focus on Diagnosis and Treatment

Overview: This lecture provided insights into the challenges and strategies associated with diagnosing and treating mental health issues in individuals with autism. It aimed to equip participants with knowledge and tools to better support this demographic.

​

​

Event: NAMI Palm Beach County; West Palm Beach, FL

Date: April 26, 2024

Presenter: Dr. Christopher Kye, MD, PA

Title: A Translational Neuroscience Approach to the Diagnosis and Treatment of Co-occurring Mental Health Conditions in Autism

Overview: This presentation delved into how co-occurring mental health conditions in autism can often be misunderstood as independent disorders. It proposed a new approach that integrates neuroscience findings specific to autism. The lecture focused on brain differences in individuals with autism and how this knowledge can be applied clinically to common psychiatric conditions. No prior understanding of the brain was required.

​